Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Protease Inhibitors/pharmacology"'
Autor:
Nadia Sukusu Nielsen, Alessandra Zarantonello, Seandean Lykke Harwood, Kathrine Tejlgård Jensen, Katarzyna Kjøge, Ida B. Thøgersen, Leif Schauser, Jesper Lykkegaard Karlsen, Gregers R. Andersen, Jan J. Enghild
Publikováno v:
Nielsen, N S, Zarantonello, A, Harwood, S L, Jensen, K T, Kjøge, K, Thøgersen, I B, Schauser, L, Karlsen, J L, Andersen, G R & Enghild, J J 2022, ' Cryo-EM structures of human A2ML1 elucidate the protease-inhibitory mechanism of the A2M family ', Nature Communications, vol. 13, no. 1, 3033 . https://doi.org/10.1038/s41467-022-30758-x
A2ML1 is a monomeric protease inhibitor belonging to the A2M superfamily of protease inhibitors and complement factors. Here, we investigate the protease-inhibitory mechanism of human A2ML1 and determine the structures of its native and protease-clea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ef422e065c3d6c50e55721068653115a
https://pure.au.dk/portal/da/publications/cryoem-structures-of-human-a2ml1-elucidate-the-proteaseinhibitory-mechanism-of-the-a2m-family(808dbc63-d7f6-49e7-97dd-6b5ef6fd65c5).html
https://pure.au.dk/portal/da/publications/cryoem-structures-of-human-a2ml1-elucidate-the-proteaseinhibitory-mechanism-of-the-a2m-family(808dbc63-d7f6-49e7-97dd-6b5ef6fd65c5).html
Autor:
Tucker, N. R., Chaffin, M., Bedi, K. C., Papangeli, I., Akkad, A. -D., Arduini, A., Hayat, S., Eraslan, G., Muus, C., Bhattacharyya, R. P., Stegmann, C. M., HCA Lung network, Zerti, Darin, Margulies, K. B., Ellinor, P. T.
Publikováno v:
Circulation
Circulation, American Heart Association, 2020, ⟨10.1161/CIRCULATIONAHA.120.047911⟩
medRxiv
Circulation, 142(7), 708-710. LIPPINCOTT WILLIAMS & WILKINS
Circulation, American Heart Association, 2020, ⟨10.1161/CIRCULATIONAHA.120.047911⟩
medRxiv
Circulation, 142(7), 708-710. LIPPINCOTT WILLIAMS & WILKINS
Coronavirus disease 2019 (COVID-19) is a global pandemic caused by a novel severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). SARS-CoV-2 infection of host cells occurs predominantly via binding of the viral surface spike protein to the hum
Autor:
Odile Burlet-Schiltz, Bernard Monsarrat, Stéphane Manenti, Marie-Pierre Bousquet-Dubouch, Mariette Matondo, Christian Recher, Sandrine Uttenweiler-Joseph, Bernard Payrastre, Nathalie Gallay
Publikováno v:
Leukemia Research
Leukemia Research, Elsevier, 2010, 34 (4), pp.498-506. ⟨10.1016/j.leukres.2009.09.020⟩
Leukemia Research, Elsevier, 2010, 34 (4), pp.498-506. ⟨10.1016/j.leukres.2009.09.020⟩
International audience; The proteasome plays a critical role in the regulation of many cellular processes, including the cell cycle and tumor growth. The proteasome inhibitor bortezomib has recently been approved for the treatment of relapsed and ref
Autor:
Moutschen, M., Hofstra, Laura Marije Arije, Sauvageot, Nicolas, Albert, Jan, Alexiev, Ivailo, Garcia, Federico, Struck, Daniel, Van, de Vijver, Åsjö, Birgitta, Beshkov, Danail, Coughlan, Suzie, Descamps, Diane, Griskevicius, Algirdas, Hamouda, Osamah, Horban, Andrzej, Van Kasteren, Marjo, Kolupajeva, Tatjana, Kostrikis, Leontios G., Liitsola, Kirsi, Linka, Marek, Mor, Orna, Nielsen, Claus, Otelea, Dan, Paraskevis, Dimitrios N., Paredes, Roger, Poljak, Mario, Puchhammer-Stöckl, Elisabeth, Sönnerborg, Anders, Staneková, Danica, Stanojevic, Maja, Van Laethem, Kristel, Zazzi, Maurizio, Zidovec Lepej, Snjezana, Boucher, Charles A. B., Schmit, Jean-Claude, Wensing, Annemarie M. J., Puchhammer-Stockl, E., Sarcletti, M., Schmied, B., Geit, M., Balluch, G., Vandamme, A. M., Vercauteren, J., Derdelinckx, I., Sasse, A., Bogaert, M., Ceunen, H., De Roo, A., De Wit, S., Echahidi, F., Fransen, K., Goffard, J. -C, Goubau, P., Goudeseune, E., Yombi, J. -C, Lacor, P., Liesnard, C., Pierard, D., Rens, R., Schrooten, Y., Vaira, D., Vandekerckhove, L. P. R., Van, den Heuvel, Van, Der Gucht, Van Ranst, M., Van Wijngaerden, E., Vandercam, B., Vekemans, M., Verhofstede, C., Clumeck, N., Van Laethem, K., Lepej, S. Z., Begovac, J., Demetriades, Ioannis, Kousiappa, Ioanna, Demetriou, Victoria L., Hezka, Johana, Linka, M., Maly, M., Machala, L., Nielsen, C., Jørgensen, L. B., Gerstoft, J., Mathiesen, L., Pedersen, C., Nielsen, H., Laursen, A., Kvinesdal, B., Liitsola, K., Ristola, M., Suni, J., Sutinen, J., Descamps, D., Assoumou, L., Castor, G., Grude, M., Flandre, P., Storto, A., Hamouda, O., Kücherer, C., Berg, T., Braun, P., Poggensee, G., Däumer, M., Eberle, J., Heiken, H., Kaiser, R., Knechten, H., Korn, K., Müller, H., Neifer, S., Schmidt, B., Walter, H., Gunsenheimer-Bartmeyer, B., Harrer, T., Hatzakis, Angelos E., Zavitsanou, Assimina, Vassilakis, A., Lazanas, Marios C., Chini, Maria C., Lioni, A., Sakka, V., Kourkounti, Sofia, Paparizos, Vassilios A., Antoniadou, Anastasia C., Papadopoulos, Antonios I., Poulakou, Garyphallia G., Katsarolis, I., Protopapas, K., Chryssos, Georgios, Drimis, Stylianos, Gargalianos, Panagiotis, Xylomenos, Georgios, Lourida, G., Psichogiou, Mina A., Daikos, George L., Sipsas, N. V., Kontos, Athanasios N., Gamaletsou, M. N., Koratzanis, Georgios, Sambatakou, H., Mariolis, H., Skoutelis, A., Papastamopoulos, V., Georgiou, O., Panagopoulos, Periklis, Maltezos, E., Coughlan, S., De Gascun, C., Byrne, C., Duffy, M., Bergin, C., Reidy, D., Farrell, G., Lambert, J., O'Connor, E., Rochford, A., Low, J., Coakely, P., O'Dea, S., Hall, W., Mor, O., Levi, I., Chemtob, D., Grossman, Z., Zazzi, M., de Luca, A., Balotta, Claudia, Riva, C., Mussini, C., Caramma, I., Capetti, A., Colombo, M. C., Rossi, C., Prati, F., Tramuto, F., Vitale, F., Ciccozzi, M., Angarano, G., Rezza, G., Kolupajeva, T., Vasins, O., Griskevicius, A., Lipnickiene, V., Schmit, J. C., Struck, D., Hemmer, R., Arendt, V., Michaux, C., Staub, T., Sequin-Devaux, C., Wensing, A. M. J., Boucher, C. A. B., van, de Vijver, van Kessel, A., van Bentum, P. H. M., Brinkman, K., Connell, B. J., van, der Ende, Hoepelman, I. M., van Kasteren, M., Kuipers, M., Langebeek, N., Richter, C., Santegoets, R. M. W. J., Schrijnders-Gudde, L., Schuurman, R., van, de Ven, Kran, A. -M B., Ormaasen, V., Aavitsland, P., Horban, A., Stanczak, J. J., Stanczak, G. P., Firlag-Burkacka, E., Wiercinska-Drapalo, A., Jablonowska, E., Maolepsza, E., Leszczyszyn-Pynka, M., Szata, W., Camacho, Ricardo J., Palma, C., Borges, F., Paixão, T., Duque, V., Araújo, F., Otelea, D., Paraschiv, S., Tudor, A. M., Cernat, R., Chiriac, C., Dumitrescu, F., Prisecariu, L. J., Stanojevic, M., Jevtovic, Dj, Salemovic, D., Stanekova, D., Habekova, M., Chabadová, Z., Drobkova, T., Bukovinova, P., Shunnar, A., Truska, P., Poljak, M., Lunar, M., Babic, Dunja Z., Tomazic, J., Vidmar, L., Vovko, T., Karner, P., Garcia, F., Paredes, R., Monge, S., Moreno, S., del Amo, J., Asensi, V., Sirvent, J. L., de Mendoza, C., Delgado, R., Gutiérrez, F., Berenguer, J., Garcia-Bujalance, S., Stella, Natalia C., de, los Santos, Blanco, J. R., Dalmau, D., Rivero, M., Segura, F., Elıás, Marıá Jesús Pérez, Alvarez, M., Chueca, N., Rodríguez-Martín, C., Vidal, C., Palomares, J. C., Viciana, I., Viciana, P., Cordoba, J., Aguilera, A., Domingo, P., Galindo, M. J., Miralles, C., del Pozo, M. A., Ribera, E., Iribarren, J. A., Ruiz, L., de, la Torre, Vidal, F., Clotet, B., Heidarian, A., Aperia-Peipke, K., Axelsson, M., Mild, M., Karlsson, A., Sönnerborg, A., Thalme, A., Navér, L., Bratt, G., Blaxhult, A., Gisslén, M., Svennerholm, B., Bergbrant, I., Björkman, Per, Säll, C., Mellgren, Å., Lindholm, A., Kuylenstierna, N., Montelius, R., Azimi, F., Johansson, B., Carlsson, M., Johansson, E., Ljungberg, B., Ekvall, H., Strand, A., Mäkitalo, S., Öberg, S., Holmblad, P., Höfer, M., Holmberg, H., Josefson, P., Ryding, U., Van Kessel, A.
Publikováno v:
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America
CLINICAL INFECTIOUS DISEASES
Clinical Infectious Diseases, 62(5), 655-663. Oxford University Press
Clinical infectious diseases, 62(5), 655-663. Oxford University Press
Clinical Infectious Diseases
Clin.Infect.Dis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Hofstra, L M, Sauvageot, N, Albert, J, Alexiev, I, Garcia, F, Struck, D, Van de Vijver, D A M C, Åsjö, B, Beshkov, D, Coughlan, S, Descamps, D, Griskevicius, A, Hamouda, O, Horban, A, Van Kasteren, M, Kolupajeva, T, Kostrikis, L G, Liitsola, K, Linka, M, Mor, O, Nielsen, C, Otelea, D, Paraskevis, D, Paredes, R, Poljak, M, Puchhammer-Stöckl, E, Sönnerborg, A, Staneková, D, Stanojevic, M, Van Laethem, K, Zazzi, M, Zidovec Lepej, S, Boucher, C A B, Schmit, J-C, Wensing, A M J & SPREAD Program 2016, ' Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe ', Clinical Infectious Diseases, vol. 62, no. 5, pp. 655-663 . https://doi.org/10.1093/cid/civ963
Clinical Infectious Diseases, 62(5), 655. Oxford University Press
CLINICAL INFECTIOUS DISEASES
Clinical Infectious Diseases, 62(5), 655-663. Oxford University Press
Clinical infectious diseases, 62(5), 655-663. Oxford University Press
Clinical Infectious Diseases
Clin.Infect.Dis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
r-INCLIVA. Repositorio Institucional de Producción Científica de INCLIVA
instname
Hofstra, L M, Sauvageot, N, Albert, J, Alexiev, I, Garcia, F, Struck, D, Van de Vijver, D A M C, Åsjö, B, Beshkov, D, Coughlan, S, Descamps, D, Griskevicius, A, Hamouda, O, Horban, A, Van Kasteren, M, Kolupajeva, T, Kostrikis, L G, Liitsola, K, Linka, M, Mor, O, Nielsen, C, Otelea, D, Paraskevis, D, Paredes, R, Poljak, M, Puchhammer-Stöckl, E, Sönnerborg, A, Staneková, D, Stanojevic, M, Van Laethem, K, Zazzi, M, Zidovec Lepej, S, Boucher, C A B, Schmit, J-C, Wensing, A M J & SPREAD Program 2016, ' Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe ', Clinical Infectious Diseases, vol. 62, no. 5, pp. 655-663 . https://doi.org/10.1093/cid/civ963
Clinical Infectious Diseases, 62(5), 655. Oxford University Press
Transmitted human immunodeficiency virus drug resistance in Europe is stable at around 8%. The impact of baseline mutation patterns on susceptibility to antiretroviral drugs should be addressed using clinical guidelines. The impact on baseline suscep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::41b36da0d354012c11ec6a9ed8516493
http://hdl.handle.net/11365/995728
http://hdl.handle.net/11365/995728
Autor:
Philippe A. Halban, Tetsuro Izumi, Shengli Zhao, Jie Wang, Toshiyuki Takeuchi, Hiromi Yokota-Hashimoto
Publikováno v:
Diabetes, Vol. 52, No 2 (2003) pp. 409-416
Autosomal dominant diabetes in the Akita mouse is caused by mutation of the insulin 2 gene, whose product replaces a cysteine residue that is engaged in the formation of an intramolecular disulfide bond. These heterozygous mice exhibit severe insulin
Autor:
Frédérique Brockly, Guillaume Bossis, Claire Acquaviva, Marc Piechaczyk, Isabelle Jariel-Encontre, Patrizia Ferrara, Cathy Salvat
Publikováno v:
Oncogene
Oncogene, Nature Publishing Group, 2001, 20 (8), pp.942--50. ⟨10.1038/sj.onc.1204155⟩
Oncogene, Nature Publishing Group, 2001, 20 (8), pp.942--50. ⟨10.1038/sj.onc.1204155⟩
c-Fos proto-oncoprotein is a short-lived transcription factor degraded by the proteasome in vivo. Its mutated forms expressed by the mouse osteosarcomatogenic retroviruses, FBJ-MSV and FBR-MSV, are stabilized two- and threefold, respectively. To eluc
Autor:
Alexandra U Scherrer, Bruno Ledergerber, Viktor von Wyl, Jürg Böni, Sabine Yerly, Thomas Klimkait, Cristina Cellerai, Hansjakob Furrer, Alexandra Calmy, Matthias Cavassini, Luigia Elzi, Pietro L Vernazza, Enos Bernasconi, Huldrych F Günthard, Swiss HIV Cohort Study
Publikováno v:
PLOS ONE, Vol. 7, No 6 (2012) P. e37983
PLoS ONE, Vol 7, Iss 6, p e37983 (2012)
PLoS ONE; Vol 7
PloS one
PLoS ONE
Scherrer, Alexandra U.; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Cellerai, Cristina; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Günthard, Huldrych F.; Swiss HIV Cohort Study, (2012). Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS ONE, 7(6), e37983. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0037983
Plos One, vol. 7, no. 6, pp. e37983
PLoS ONE, Vol 7, Iss 6, p e37983 (2012)
PLoS ONE; Vol 7
PloS one
PLoS ONE
Scherrer, Alexandra U.; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; Yerly, Sabine; Klimkait, Thomas; Cellerai, Cristina; Furrer, Hansjakob; Calmy, Alexandra; Cavassini, Matthias; Elzi, Luigia; Vernazza, Pietro L.; Bernasconi, Enos; Günthard, Huldrych F.; Swiss HIV Cohort Study, (2012). Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients. PLoS ONE, 7(6), e37983. Lawrence, Kans.: Public Library of Science 10.1371/journal.pone.0037983
Plos One, vol. 7, no. 6, pp. e37983
Background Minor protease inhibitor (PI) mutations often exist as polymorphisms in HIV-1 sequences from treatment-naive patients. Previous studies showed that their presence impairs the antiretroviral treatment (ART) response. Evaluating these findin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7322ddc0fddb37cfc7322f0a1a05e5f5
https://doi.org/10.5167/uzh-67852
https://doi.org/10.5167/uzh-67852
Autor:
Danielle Baeyens-Volant, Mohamed Azarkan, Abel Garcia-Pino, Lieven Buts, Sergio Martínez-Rodríguez
Publikováno v:
The Journal of biological chemistry, 286 (51
Proteases carry out a number of crucial functions inside and outside the cell. To protect the cells against the potentially lethal activities of these enzymes, specific inhibitors are produced to tightly regulate the protease activity. Independent re
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e0a50f3f4864fa7b74bbac900efbd1ab
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/110371
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/110371
Autor:
Peter Reiss, Jitske de Vries-van der Weij, Yanan Wang, Teake Kooistra, Marion A.M. den Boer, Louis M. Havekes, Marit Westerterp, Lihui Hu, Sonia M. S. Espirito Santo, Patrick C.N. Rensen, Johannes A. Romijn
Publikováno v:
ATHEROSCLEROSIS, 210(2), 381-387. ELSEVIER IRELAND LTD
Atherosclerosis, 210(2), 381-387. Elsevier Ireland Ltd
Atherosclerosis, 210(2), 381-387
Atherosclerosis, 2, 210, 381-387
Atherosclerosis, 210(2), 381-387. Elsevier Ireland Ltd
Atherosclerosis, 210(2), 381-387
Atherosclerosis, 2, 210, 381-387
Objective: The use of the HIV-protease inhibitor ritonavir (RTV) is associated with induction of hypertriglyceridemia, which is a cardiovascular risk factor. Therefore, we investigated the effect of RTV on atherosclerosis development in APOE*3-Leiden
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a212f8605e8e4c9b1fa6432f8d6066f
https://hdl.handle.net/1887/110771
https://hdl.handle.net/1887/110771
Publikováno v:
Biological chemistry, vol. 387, no. 6, pp. 723-731
Human kallikrein 8 (hK8), whose gene was originally cloned as the human ortholog of a mouse brain protease, is known to be associated with diseases such as ovarian cancer and Alzheimer's disease. Recombinant human pro-kallikrein 8 was activated with